Since the early 1990s, the evidence has been inconclusive as to whether using hormonal contraception increases women’s risk of acquiring HIV, particularly among progestogen-only injectable users. Observational studies indicated that women using progestogen-only injectable contraceptive methods may be at higher risk of acquiring human immunodeficiency virus (HIV).  The ECHO trial finds no link between HIV acquisition and the use of DMPA-IM, progestogen implant, and non-hormonal copper IUD. 

Universal health coverage means ensuring every person has access to quality, affordable health services and plays a pivotal role in achieving global development targets. Healthy populations can better contribute socially and economically, while poor health is a major driver of poverty. Universal access to sexual and reproductive health care services is identified in the Sustainable Development Goals as an essential contributor to ensuring healthy lives and promoting well-being for all at all ages. IPPF, together with the London School of Hygiene and Tropical Medicine, undertook a literature review looking at progress to date in and challenges to achieving universal access to sexual and reproductive health and rights. The review, Leaving no one behind, is illustrated with case studies on Afghanistan, Cambodia, Kenya and Sudan. Supported by the Japan Trust Fund.

World AIDS Day: “Can I get HIV from kissing?” and other questions answered1 December is World AIDS Day, an opportunity for us all to unite in the fight against HIV, to stand in solidarity with the 36.9 million people living with HIV around the world, and to commemorate those who have died from an AIDS-related illness. Over the past few decades, HIV and AIDS have been discussed a lot, but what do you really know about them? Find out in our quiz >> 1/10. True or false: HIV and AIDS are the same thing2/10. How might HIV be transmitted from one person to another?3/10. If both sexual partners have HIV, then they don’t need to worry about using condoms – true or false?4/10. There are 36.9 million people living with HIV globally. How many of them are not aware of their HIV status?5/10. Can people living with HIV safely have children?6/10. HIV only affects certain groups of people – true or false?7/10. Which of the following is the best way to prevent transmission of HIV and other STIs?8/10. True or false: If you have taken an HIV test already, then you don't need to do it again9/10. How long should you wait before going for an HIV test?10/10. What does being “undetectable” mean?Good try! If you learned something new today, scroll down to share this with friends :point_down:Pretty good! If you learned something new today, scroll down to share this with friends :point_down:Great work! If you learned something new today, scroll down to share this with friends :point_down:

In May 2018, the World Health Organization (WHO) reported a potential safety issue concerning dolutegravir (DTG), a common first-line antiretroviral treatment drug that is used to prevent and treat HIV infections. Preliminary findings from a study in Botswana found an increased risk of neural tube defects in infants born to women taking DTG at the time of conception. As a result of this study, WHO’s revised guidance on antiretroviral regimens for treating and preventing HIV infections, released in July 2018, include a caution on use of DTG by women and adolescent girls of childbearing potential. This brief aims to provide an overview of the research to date, current WHO guidance, and recommendations for IPPF.

Injectable contraceptives are an increasingly popular method of family planning. They are safe, discrete, highly effective, and generally last for several months. Sayana® Press, also known as subcutaneous depot medroxyprogesterone (DMPA‑SC), is a lower‑dose formula version of the already popular injectable Depo‑Provera. DMPA‑SC combines the drug and needle in a single‑use unit, which makes it easy to transport and simple to use with little training. DMPA‑SC can be administered by community health workers (CHWs) and women themselves – potentially making injectable contraceptives available to women who can’t easily travel to clinics.

Emergency contraception (EC) refers to any contraceptive method that can be used after having unprotected or inadequately protected sexual intercourse (UPSI) but before pregnancy occurs, providing women with the opportunity to prevent an unwanted pregnancy. EC is a safe and effective method for preventing unwanted pregnancy and can reduce the risk of pregnancy by up to 99%. In spite of its effectiveness, EC is not frequently used. In many countries, women face barriers to accessing EC. The majority of women in low‑income countries are unaware of EC. Moreover, some providers have negative attitudes toward providing EC to women and girls.